For: | Reddy A, May E, Ehrinpreis M, Mutchnick M. Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C. World J Gastroenterol 2013; 19(48): 9328-9333 [PMID: 24409059 DOI: 10.3748/wjg.v19.i48.9328] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i48/9328.htm |
Number | Citing Articles |
1 |
Minjie Wang, Yuting Wang, Xiaoshuang Feng, Ruijun Wang, Yanmei Wang, Hongmei Zeng, Jun Qi, Hong Zhao, Ni Li, Jianqiang Cai, Chunfeng Qu. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer Center. International Journal of Infectious Diseases 2017; 65: 15 doi: 10.1016/j.ijid.2017.09.003
|
2 |
S. Simona Jakab. Liver and Pancreatic Cancer Related to Hepatitis B Exposure. Journal of Clinical Gastroenterology 2014; 48(8): 655 doi: 10.1097/MCG.0000000000000163
|
3 |
Nicola Coppola, Lorenzo Onorato, Caterina Sagnelli, Evangelista Sagnelli, Italo F. Angelillo. Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease. Medicine 2016; 95(30): e4311 doi: 10.1097/MD.0000000000004311
|
4 |
Hanan Omar, Samaa Taha, Wafaa Hassan, Hamdy Omar. Occult hepatitis B infection: a hidden factor of poor response to intervention treatment of hepatocellular carcinoma in chronic hepatitis C patients. Comparative Clinical Pathology 2018; 27(5): 1273 doi: 10.1007/s00580-018-2735-0
|
5 |
Kiyohiko Omichi, Junichi Shindoh, Satoshi Yamamoto, Yutaka Matsuyama, Nobuhisa Akamatsu, Junichi Arita, Junichi Kaneko, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Norihiro Kokudo. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection. Annals of Surgical Oncology 2015; 22(S3): 1034 doi: 10.1245/s10434-015-4845-0
|
6 |
Erin E. Conners, Lakshmi Panagiotakopoulos, Megan G. Hofmeister, Philip R. Spradling, Liesl M. Hagan, Aaron M. Harris, Jessica S. Rogers-Brown, Carolyn Wester, Noele P. Nelson, Karina Rapposelli, Amy L. Sandul, Elisa Choi, Carla Coffin, Kristen Marks, David L. Thomas, Su H. Wang. Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023. MMWR. Recommendations and Reports 2023; 72(1): 1 doi: 10.15585/mmwr.rr7201a1
|
7 |
Fei Wang, Jin-Lian Yang, Ke-ke Yu, Mei Xu, You-zhi Xu, Li Chen, Yan-min Lu, Hao-shu Fang, Xin-yi Wang, Zhong-qian Hu, Fei-fei Li, Lixin Kan, Jia Luo, Si-Ying Wang. Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma. Molecular Cancer 2015; 14(1) doi: 10.1186/s12943-014-0274-0
|
8 |
Nicola Coppola, Lorenzo Onorato, Mariantonietta Pisaturo, Margherita Macera, Caterina Sagnelli, Salvatore Martini, Evangelista Sagnelli. Role of occult hepatitis B virus infection in chronic hepatitis C. World Journal of Gastroenterology 2015; 21(42): 11931-11940 doi: 10.3748/wjg.v21.i42.11931
|
9 |
Hao Zhang, Biqing Zhu, He Zhang, Jianxin Liang, Wenting Zeng. HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/3417976
|
10 |
Jiarong Zhou, Nishta Krishnan, Yao Jiang, Ronnie H. Fang, Liangfang Zhang. Nanotechnology for virus treatment. Nano Today 2021; 36: 101031 doi: 10.1016/j.nantod.2020.101031
|